Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole vs Fulvestrant in Neoadjuvant Breast Cancer
NCT00871858Phase 2Completed
- Sponsor
- Institut Bergonié
- Start
- Mar 2008
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by Institut Bergonié. Started Mar 2008; status: completed.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00871858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871858.